Vascular alpha 1D-adrenoceptors: are they related to hypertension?

R Villalobos-Molina1, M Ibarra

  • 1Departamento de Farmacología y Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, México, D.F., Mexico. rvmolina@hotmail.com

Insights

Vascular alpha 1D-adrenoceptors are key in blood pressure regulation, especially with aging and hypertension. This review explores their role in developing and maintaining high blood pressure.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Cardiovascular Physiology

Background:

  • Vascular alpha 1-adrenoceptors exhibit subtype heterogeneity (alpha 1A, alpha 1B, alpha 1D).
  • The alpha 1D-adrenoceptor subtype significantly influences vascular contraction and blood pressure control.
  • Aging is associated with altered adrenoceptor function and blood pressure regulation.

Purpose of the Study:

  • To review the involvement of the alpha 1D-adrenoceptor subtype in the genesis and maintenance of hypertension.
  • To discuss the role of alpha 1D-adrenoceptors in age-related blood pressure changes.

Main Methods:

  • Pharmacological studies identifying adrenoceptor subtypes.
  • Molecular biology techniques characterizing adrenoceptor expression.
  • Studies using pre-hypertensive and hypertensive rat models (one kidney, Grollman-type renal hypertension).

Main Results:

  • Evidence suggests predominant involvement of the alpha 1D-adrenoceptor in vascular contraction.
  • Studies in hypertensive rat models indicate a role for vascular alpha 1D-adrenoceptors in elevated blood pressure.
  • Potential link between alpha 1D-adrenoceptor activity and age-related hypertension.

Conclusions:

  • The alpha 1D-adrenoceptor is a significant factor in vascular tone and blood pressure regulation.
  • Vascular alpha 1D-adrenoceptors are implicated in the development and persistence of hypertension.
  • Further research into alpha 1D-adrenoceptor function may offer therapeutic targets for hypertension.

Related Concept Videos

Adrenergic Receptors (Adrenoceptors): Classification01:27

Adrenergic Receptors (Adrenoceptors): Classification

Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers01:22

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...